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5-Hydroxymethylfurfural (HMF) has emerged as a crucial bio-based chemical building block
in the drive towards developing materials from renewable resources, due to its direct pre-
paration from sugars and its readily diversifiable scaffold. A key obstacle in transitioning to
bio-based plastic production lies in meeting the necessary industrial production efficiency,
particularly in the cost-effective conversion of HMF to valuable intermediates. Toward
addressing the challenge of developing scalable technology for oxidizing crude HMF to more
valuable chemicals, here we report coordinated reaction and enzyme engineering to provide a
galactose oxidase (GOase) variant with remarkably high activity toward HMF, improved O2
binding and excellent productivity (>1,000,000 TTN). The biocatalyst and reaction condi-
tions presented here for GOase catalysed selective oxidation of HMF to 2,5-diformylfuran
offers a productive blueprint for further development, giving hope for the creation of a
biocatalytic route to scalable production of furan-based chemical building blocks from sus-
tainable feedstocks.
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B iomass waste is an abundant, carbon-rich renewable feed-stock that, if processed efficiently, could provide access tomany chemicals and fuels as an alternative to those pro-
duced from fossil resources. The sugars component of biomass
can be chemically dehydrated to give furfural and
5-hydroxymethylfurfural (HMF), of which the latter has been
identified by the U.S. Department of Energy as one of the top 12
potential platform chemicals from renewable feedstocks1. HMF
can be transformed through different reactions to produce a
range of derivatives, many having applications in the polymer
industry2–4. In particular, the oxidized HMF derivatives 2,5-
diformylfuran (DFF) and furan-2,5-dicarboxylic acid (FDCA) are
both important intermediates in furan based polymer synthesis
(Fig. 1), as they can be condensed with other monomers to make
poly-imines, -esters, -amides and -urethanes as plastics, resins
and porous organic frameworks2,5,6. In addition to more envir-
onmentally responsible manufacturing methods7, many of these
bio-based plastics have properties that rival those produced from
petroleum resources, such as the polyethylene furanoate ‘drop in’
replacement for polyethylene terephthalate8,9, and some even
display unique properties of potential use in performance
materials10,11.
The primary obstacles preventing the necessary industrial scale
production of these furan-based plastics are (1) an inexpensive,
continuous and large supply of the basic materials from renew-
able resources, (2) an efficient and cost effective process to con-
vert them to monomer units, and (3) effective implementation at
a production scale that meets the consumer demand. Recent
advances in reaction engineering using both inorganic and acid
catalysts have enabled high yielding conversions of carbohydrates
to HMF4,12–17. Yet HMF is unstable, and often needs to be
purified to remove salts and by-products left as impurities prior
to further chemical conversion, in order to avoid catalyst
poisoning4,14,18. Once in hand, HMF can be oxidized by a variety
of metal catalysts or electrochemical methods to produce DFF,
FDCA, or the dimethyl ester of FDCA (furan dicarboxylic methyl
ester, FDME) which are more stable monomers2,4,19,20. However,
these reactions are frequently performed at elevated temperatures
and pressures, which can be energy intensive and therefore
counterproductive to the aim of developing a sustainable process.
Preferably, biocatalytic oxidation of HMF to these valuable
derivatives could extend the sustainability of these bio-based
chemicals to include a more environmentally friendly production
process. However, this activity is limited to only a few
enzymes21,22, primarily chloroperoxidases23, HMF oxidases
(HMFO)24, aryl-alcohol oxidases25,26, and galactose oxidases
(GOase) and related copper radical oxidases27–29. The latter three
seem to be the most appealing due to their dependence on oxygen
as a co-substrate rather than H2O2 as in peroxidases or NAD(P)+
as in dehydrogenases. Nevertheless, this presents a number of
issues when working at scale due to limitations in oxygen solu-
bility in aqueous media and thereby supply, that can significantly
impact biocatalyst performance30–34. HMF oxidases and aryl-
alcohol oxidases are also interesting in that they catalyse the
complete oxidation of HMF to FDCA24–26,35–37. In analogous
two-enzyme systems, GOase has been combined with periplasmic
aldehyde oxidase PaoABC28 or unspecific peroxygenase38,39 to
create an oxidative cascade from HMF to FDCA. However,
productivity and selectivity of these systems are not yet adequate
for large-scale implementation, and none provide access to DFF
as the final product and our desired target. In fact, DFF has been
particularly challenging to selectively synthesize efficiently (che-
mically or biocatalytically) without requiring high levels of (bio)
catalyst22,40,41, but GOase and related copper radical oxidases do
provide DFF as the main product27–29.
Building on our previous work in understanding the effect of
reaction conditions on GOase for alcohol oxidation (critically, the
inclusion of horseradish peroxidase (HRP) to activate GOase and
catalase to remove destructive H2O2)42, we have engineered
GOase for improved kinetic properties for both alcohol oxidation
and oxygen binding to deliver a variant that exhibits particularly
high catalytic activity for HMF oxidation to selectively produce
DFF. Coordinated reaction engineering led to further improve-
ments in conversion and demonstrated that a GOase-based
synthesis is amenable to the necessary process intensification
required for ultimate industrial implementation. This approach
comprising coordinated reaction and enzyme engineering43,44 has
resulted in an effective and high yielding model system for the
selective bio-oxidation of HMF to DFF at high substrate loading.
Results and discussion
For DFF, FDCA and their derivatives to be relevant for use in bio-
based plastics, the scale of production needs to meet a market
demand, and the production process needs to be cost competitive
compared to current methods of producing the non-bio-based
monomer equivalents. We began by defining a set of proof of
principle reaction metric targets to guide our approach based on
estimated threshold values for a biocatalytic processes in the bulk
chemical sector45,46 (Table 1). These metrics were then used to
help define which aspects were still in need of improvement
before potential future implementation in a true industrial
process.
Our approach began with enzyme engineering that was guided
by reaction constraints to directly develop a biocatalyst that was
industrially relevant, applying screens to select for improvement
in turnover rate and for improvements in activity at low oxygen
levels. Biocatalyst development was balanced by concurrent,
iterative reaction development to tune conditions and push per-
formance limits to identify scalable conditions. This also served as
a secondary selection process to identify the top performing
variants under potential process conditions. As such, the
laboratory scale experiments were performed with the end goal of
scale-up in mind. These two approaches proved cooperative,
using the results of one to help guide modifications to the other in
a so-called ‘ideal scenario’ of process and biocatalyst driven
Fig. 1 Diversification of HMF to high value products via DFF intermediate.
Bio-derived HMF can be chemically and/or enzymatically converted to
various other furans that are useful as intermediates or monomers. HMF, 5-
(hydroxymethyl)furfural. DFF, 2,5-diformylfuran. HMF-OH, 2,5-bis
(hydroxymethyl)furan. BAMF, 2,5-bis(aminomethyl)furan. FDCA, 2,5-
furandicarboxylic acid.
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process design44,47. In the interests of clarity, work on these
approaches is discussed in two separate subsections below, despite
being coordinated and occurring simultaneously.
Enzyme engineering. The first round of library generation tar-
geted pairs of active site residues (Fig. 2), and screening against
1-hexanol identified variant M4 (M3–5 + Y329L/M330F muta-
tions) as being the top performing hit (Supplementary Note).
Residues outside the active site were also targeted to randomly
recombine previously published beneficial mutations into M4.
Mutated sites in variants published by Delagrave et al. (variant
7.5.1 with C383S/Y436H/N318D/V477D/A626S/V494A)48,
Wilkinson et al. (variant C383S/Y436H)49, and Deacon and
McPherson (C383S and C383T)50 were chosen as sites for
potential non-selective catalytic improvements. None of these
residues interact directly with the substrate (Supplementary
Fig. 1), but each variant showed increases in kcat,app, reductions in
KM,app, or both. Mutations other than V494A, which was already
present in GOase since the M1 variant (Supplementary Table 1),
were randomly introduced to create a library of unique combi-
nations and screened for activity on 1-hexanol. The top hits
identified from this screen were variants M5-1 (V477D/A626S),
and M5-2 (N318D/C383T/Y436H/V477D). Interestingly, these
hits had distinct sequences compared to the previously published
variants. Kinetic characterization of these two variants showed
very similar parameters compared to the progenitor (Table 2),
therefore, it is possible that the mutations have more influence on
GOase expression and/or stability, which contributed to their
detection in the screen.
A universal issue in the application of oxygen-dependent
enzymes revolves around the balance of providing sufficient
oxygen to the bioreactor while minimizing potential enzyme
deactivation at the gas-liquid interface and potentially stripping
volatile substrate(s), product(s) and/or co-solvent33,51. Oxygen
has a low solubility in aqueous solution (~270 µM)31,33,52, while
KM for O2 (KMO) for many enzymes is often estimated to be
much higher than the oxygen concentration in equilibrium with
air33,53. This difference means that reaction rates will be
dependent upon the oxygen concentration in the liquid and
thereby on oxygen transfer rates42. This limitation is magnified at
high substrate loadings, where substrate concentration and
oxygen concentration can differ by a factor of up to 103 30,32.
The problem results in a system that often prevents the enzyme
from operating at maximum performance, and therefore other
strategies are required.
One approach to overcome the oxygen problem is to improve the
KMO of the biocatalyst, or in other words, engineer the enzyme to
work more effectively at lower oxygen concentrations42,54–57.
Likewise, improvements in kcat/KMO (catalytic efficiency for
oxygen) will be more beneficial than improvements in kcat/KMS
(where KMS is the KM for the target substrate). Because the active
site of GOase is fairly exposed on the surface of the enzyme,
residues nearest to the active site Cu2+ ion were expected to have
the greatest impact on oxygen binding and reactivity. The solid
phase assay proved to be amenable for use within a glovebox,
allowing the screen to be performed in a controlled environment
containing a low O2 atmosphere (around 0.2% v/v, see Supple-
mentary Note). Using this format, active site libraries C, D, and E
(Fig. 2) on the GOase M4 template were screened for improved
GOase activity at low oxygen levels using HMF as substrate. Despite
the low oxygen concentration, multiple potential hits from libraries
C and D were identified. Upon confirmation in a secondary screen
and basic characterization in analytical scale biotransformations to
challenge these newest variants in current reaction conditions (see
below), GOase M6-A (F290W/S291S) was identified as the top
performing variant. Additionally, one potential hit from library C
(variant M6-B, with F290W/S291R mutations) was identified after
quickly producing a uniquely large spot on the assay plate following
removal after several hours of incubation at the low oxygen
atmosphere. The common mutation between these two variants is
the reversion of F290 to tryptophan, which is the residue found in
the wild-type enzyme and the early GOase M1 variant58, but was
mutated to phenylalanine during engineering of the GOase M3
Table 1 Target proof of principle reaction metrics for
oxidation of HMF to DFF by GOase.
Unit Target
Final Prod. Conc. g/L 100
Duration h 25
Productivity g/L.h 4
Specific Yielda gProduct/gBiocatalystb 1000
Conversion % 98
Isolated Yield % 98
Purity % >98
aSpecific yield is defined as (mass product over the biocatalyst lifetime)/(mass biocatalyst).
bgBiocatalyst taken as pure enzyme or pure enzyme equivalent in CFE based on specific activity.
Fig. 2 Active site residues targeted for mutagenesis. Positions of active
site residues targeted in the seven GOase M3–5 NNK CASTing libraries,
displayed on wildtype GOase crystal structure (PDBID: 1GOG). Libraries
A–G were: A (green): 406/407, B (blue): 326/330, C (pink): 290/291,
D (purple): 194/195, E (cyan): 463/464, F (green): 405/406 and G (blue):
329/330.
Table 2 Apparent kinetic parameters for GOase variants
with HMF.
Variant Name kcat,app (s−1) KM,app (mM) kcat/KM (s−1 M−1)
M3–5 123.9 ± 1.4 3.3 ± 0.1 38000 ± 1000
M4 132.7 ± 2.6 2.1 ± 0.2 63000 ± 6000
M5-1 153.9 ± 4.2 2.0 ± 0.2 77000 ± 8000
M5-2 139.0 ± 2.4 1.8 ± 0.1 77000 ± 4000
M6-A 200.5 ± 13.7 10.6 ± 2.8 19000 ± 5000
M6-B 115.4 ± 6.6 15.8 ± 2.9 7300 ± 1400
M7-1A 246.2 ± 10.7 15.3 ± 2.2 16000 ± 2000
M7-2A 204.6 ± 10.7 14.5 ± 2.6 14000 ± 3000
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variant59 (Supplementary Table 1). It appears that W290 has a
significant impact on substrate (HMF and/or O2) binding and
catalysis since the kcat,app for HMF in the M6-A variant increased by
50%, while the KM,app increased by approximately 5-fold (Table 2).
The KM,app for M6-B was similarly affected, although there was little
change in kcat,app indicating that the S291R mutation counteracts
the beneficial effect of the F290W mutation in this variant.
The final round of enzyme engineering was based on merging the
results of the two evolution strategies to create the M7-1A, M7-2A,
M7-1B, and M7-2B variants (Supplementary Table 1). M7-1A and
M7-2A were kinetically characterized, revealing an increase in kcat,app
to 246 s−1 for M7-1A (Table 2), which compares quite favourably to
FAD-dependent enzymes that oxidize HMF24–26,36,37, and is
similar to another copper radical oxidase variant27. In this instance,
the combination of mutations from M5-1 and M5-2 with M6-A
appears to be additive, which is a reflection of the non-specific
catalytic enhancement provided by such distal mutations.
The kinetic measurements above are apparent values since they
were determined under oxygen limited conditions. A more
complete dataset was collected for selected GOase variants using
the recently developed Tube-in-Tube Reactor (TiTR)60, which
has enabled a simplified method for accurately determining true
kinetic parameters for oxygen-dependent enzymes, specifically
KMO33. The variants chosen for these detailed characterizations
were selected to sample the improvements over the course of the
engineering program in comparison to the wild-type (M1)
variant: the initial M3–5 progenitor, the first hit for improved
HMF activity (M4) and the top hit from the low O2 screen (M6-A).
KMO values changed significantly over the course of evolution,
increasing drastically in early variants before returning to wild-
type levels after screening in the low oxygen environment
(Table 3). The influence of KMO can be observed by comparison
of the TiTR data with the apparent kinetic parameters reported in
Table 2. Measurements for the M4 and M6-A variants are fairly
consistent between the two experiments as a result of KMO values
near or below the level of aqueous O2 concentration in
equilibrium with air (~270 µM and 30 °C). However, the high
KMO for GOase M3–5 shows that this variant was severely oxygen
limited in the standard kinetic assay and was therefore much
more responsive to the increase in aqueous O2 concentration in
the TiTR. The improvement in kcat/KMO found in the M6-A
variant as a result of the low oxygen assay conditions highlights
the value of using this screen for engineering oxygen dependent
enzymes, and confirms that it is indeed possible to intentionally
target and improve reactivity in GOase. Furthermore, we believe
that this glovebox modification could be generally applied to
provide a unique selective pressure for engineering KMO in other
oxygen-dependent enzymes, which could significantly accelerate
their development for use at industrial scale.
Reaction engineering. Reaction engineering for the GOase cat-
alysed oxidation of HMF to DFF was performed alongside the
enzyme engineering work, incorporating newly improved variants
and substrate formulations as they became available. These
reactions were also used as a secondary assay to evaluate per-
formance of hits from library screens to identify best performing
variant of the round of evolution. Initial reaction compositions
and conditions were based on our previously published work42
and were then adapted in stages to target the effects of individual
parameters. As described below, this approach allowed an
assessment of the limits for a given variant while also considering
requirements of future process implementation.
Initial reactions to characterise over-oxidation of DFF to 5-
formyl-2-furan carboxylic acid (FFCA) by GOase variants61
indicated that this was not a concern, and identified M4 as the
more effective biocatalyst for HMF oxidation (Supplementary
Note and Supplementary Table 2). From there, we next started a
process of reaction optimization beginning with screening for
compatible co-solvents. An initial screen of typical solvents
highlighted DMSO as a beneficial and compatible solvent, and
0.05 g/L (0.71 µM) purified GOase as an ideal working biocatalyst
loading giving high conversion (94%) of 100 mM HMF and good
conversion (71%) of 250 mM HMF (Supplementary Note and
Supplementary Tables 3 and 4). Additionally, GOase M4
performed well when challenged with a preparation of crude
HMF from BASF (71% conversion of 25 g/L, Supplementary
Table 5). An important consideration in the accessibility of furan-
based materials from biomass is the processing necessary to
convert the crude HMF into a formulation suitable for the
subsequent reaction. As mentioned, HMF is frequently required
in the purified form before it can be converted satisfactorily by
many inorganic catalysts, thus the option to overcome such
purification requirements by using crude HMF could lead to
significantly reduced production costs. Similarly, use of a crude
biocatalyst formulation such as dried cell free extract could prove
more cost-effective. In the first instance, an approximately
equivalent GOase M4 loading of dried CFE formulation (5–6%
GOase by weight) gave slightly higher conversions than the
purified enzyme (66% conversion compared to 50% at 250 mM,
Supplementary Table 6).
Attempting to remove DMSO to avoid future process
complications resulted in reduced productivity (comparing
Supplementary Table 4 Entry 3 and Supplementary Table 6
Entry 1). To find a more suitable solvent for scale-up, we then
examined M4 performance in a variety of water-miscible and
-immiscible co-solvents (Supplementary Tables 7 and 8), in
addition to the effect of reaction temperature (Supplementary
Table 9). The most promising results were observed when using
ethyl acetate (EtOAc) at 20 °C. It is expected that both the
addition of a water-immiscible organic solvent and the
lower temperature contribute to improved biocatalyst stability
by reducing the aqueous concentration of the dialdehyde
product. Dialdehydes are common crosslinking reagents62 and
can modify accessible lysine residues (22 in the case of this
construct), often reducing enzyme activity and stability. Accord-
ingly, effective removal of the DFF product should enable higher
conversions.
Table 3 Kinetic parameters of GOase variants determined in the TiTR with HMF.
Variant KMO (mM) KMS (mM) kcat (s−1) kcat/KMO (M−1 s−1) kcat/KMS (M−1 s−1)
M1 0.16 ± 0.11 53 ± 18 23.5 ± 4.7 (1.5 ± 1.1) × 105 (0.04 ± 0.02) × 104
M3–5a 1.39 ± 0.46 14.9 ± 4.5 651 ± 132 (4.7 ± 1.8) × 105 (4.4 ± 1.6) × 104
M4 0.37 ± 0.07 1.83 ± 0.30 120 ± 6 (3.3 ± 0.6) × 105 (6.6 ± 1.1) × 104
M6-A 0.15 ± 0.02 6.19 ± 0.41 166 ± 4 (10.9 ± 1.5) × 105 (2.7 ± 0.2) × 104
KMO: KM for oxygen, KMS: KM for HMF. aMeasured using CFE powder with an estimated GOase content, giving a higher uncertainty in the kcat parameter. Data previously published in the PhD thesis of A.
T. P.77.
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Integrating these two beneficial reaction features (i.e. 20 °C and
EtOAc layer) gave an improved set of performance metrics:
almost complete conversion of 250 mM HMF and 25 g/L crude
HMF by GOase M4 as purified enzyme and as CFE after 6 h,
suggesting that substrate loading could be pushed still higher
(Table 4 and Supplementary Table 10). Indeed, under the same
conditions, conversion to DFF reached 71% of 500 mM HMF and
82% of 50 g/L crude HMF by M4 CFE after 6 h.
Large scale application of GOase will likely require a continuous
supply of air (or oxygen enriched air) to meet the oxygen
requirements for substrate conversion. Consequently, low boiling
solvents, such as EtOAc (bp 77 °C), would be stripped out of the
reaction vessel, even with the installation of an effective condenser.
We therefore evaluated organic solvents with lower vapour
pressures but with log P values similar to EtOAc (Supplementary
Note, Supplementary Fig. 2). Co-solvents that proved to be more
beneficial and compatible with GOase were esters, carbonates and
ethers, with diethyl carbonate (DEC, bp 126°) and butyl acetate
(BuOAc, bp 126 °C) identified as the most promising (for
unfavourable solvents, see Supplementary Note). DEC was found
to give comparable levels of conversion at both 250 and 500mM
HMF using purified GOase M4, and also at 50 g/L crude HMF
when using GOase M4 as CFE (Table 5 and Supplementary
Table 11). This high level of conversion of crude HMF by the
unpurified GOase preparation as CFE (Table 5 Entry 2) now
approaches industrially relevant metrics (Table 1), while utilizing a
biocatalyst formulation that is more realistic for industrial
application. Working at these high substrate loadings, we
suspected that the benefits of the biphasic reaction were two-
fold. In effect, the second liquid phase was acting as a reservoir
both for HMF as well as DFF, continuously feeding the substrate
while extracting the product. These expectations are generally
supported by the experimentally determined partition of HMF
and DFF between the aqueous and organic layers (Supplementary
Table 12).
The four newly identified Round 2 GOase variants displayed
greatly improved conversion of 50 g/L semi-crude HMF com-
pared to the M4 variant (see Supplementary Note and
Supplementary Table 13), with the best variant (M6-A) reaching
nearly 90% conversion after 6 h. This was particularly significant
since the variants were engineered in two distinctly different
screening strategies: in one case targeting distal residues for
increased kcat, and in the other targeting active site residues for
lower KMO. The combination of these mutations in Round 3
variants M7-1A, M7-2A, M7-1B and M7-2B led to an additive effect
and still greater conversion than the parental variants (up to 81%)
when tested at 100 g/L semi-crude HMF (Table 6). All variants
holding the unique M6-A ‘A’ mutations (F290W/S291S) had a
faster rate of conversion and high overall conversion, which
reflects the increased kcat,app values measured for these variants
(Table 2). Additionally, variants having the unique M6-B ‘B’
mutations (F290W/S291R), were the only variants that showed a
significant increase in conversion after the 6 h time point,
suggesting that the additional S291R has a beneficial effect on
stability, potentially via formation of a salt bridge with E195.
However, the S291R mutation appears to prevent a similar
improvement in turnover rate provided by F290W in the M6-A
variant.
With an interest to identify a broader range of solvents that
could potentially improve downstream processing of the reaction,
Table 4 Conversion of HMF to DFF by GOase variant M4 CFE using EtOAc overlay at reduced incubation temperature.
Entry GOase
Variant
GOase (g/L) GOase Form HRP (g/L) [HMF] Type HMF Conversion (%) Over-
oxidation (%)
1 M4 0.625 CFE 0.0128 250mM Pure 96 2.5
2 M4 0.625 CFE 0.0128 25 g/L Crude 88 6.4
3 M4 0.625 CFE 0.0128 500mM Pure 71 0.4
4 M4 0.625 CFE 0.0128 50 g/L Crude 82 0.8
Data for reactions with purified enzyme provided in Supplementary Table 10. Conditions listed in the table highlight the main differences between samples, while those listed below the table apply to all
entries unless otherwise stated.
Conditions: 0.05 mM CuSO4 in GOase M4 CFE reactions, 880 U/mL Catalase, 100mM NaPi, 200 µL (80% of aqueous volume) EtOAc, 20 °C, 6 h.
Table 5 Conversion of HMF to DFF by GOase variant M4 CFE at high HMF loading in the presence of different cosolvents.
Entry GOase Variant GOase (g/L) GOase Form HRP (g/L) Co-Solvent [HMF] (g/L) Type HMF Conversion (%) Over-oxidation (%)
1 M4 0.625 CFE 0.0128 EtOAc 50 Crude 82 0.8
2 M4 0.625 CFE 0.0128 DEC 50 Crude 82 0.8
3 M4 0.625 CFE 0.0128 BuOAc 50 Crude 76 0.7
Data for reactions with purified enzyme provided in Supplementary Table 11. Conditions listed in the table highlight the main differences between samples, while those listed below the table apply to all
entries unless otherwise stated.
Conditions: 0.05 mM CuSO4 in GOase M4 CFE reactions, 880 U/mL Catalase, 100mM NaPi, 200 µL (80% of aqueous volume) solvent overlay, 20 °C, 6 h.








1/2 M4 31 31
3/4 M5-1 38 39
5/6 M5-2 51 54
7/8 M6-A 57 62
9/10 M6-B 59 76
11/12 M7-1A 64 69
13/14 M7-2A 77 77
15/16 M7-1B 64 81
17/18 M7-2B 58 78
Conditions: 0.05 g/L pure enzyme, 0.0064 g/L HRP, 880 U/mL Catalase, 100mM NaPi, 100 g/
L Crude HMF in DEC (BASF), 200 µL (80% of aqueous volume) DEC, 20 °C, 6 and 24 h. Over-
oxidation in all samples was found to be <0.3%.
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several other co-solvents that offered slightly different physical
properties (density, Log P, water solubility, boiling point, etc.,
Supplementary Table 14) were identified for compatibility testing
with GOase. Of these solvents, diethyl malonate, diethyl
succinate, and ethylene glycol diacetate (DEM, DES and EGDA,
respectively) gave similar conversions as the standard reaction
with DEC at 100 g/L semi-crude HMF, while all others gave
significantly lower conversion (Supplementary Fig. 3). These four
solvents (DEC, DEM, DES and EGDA) were then used to
evaluate the top performing GOase variants (M6-B, M7-2A, M7-1B
and M7-2B) challenged with 150 g/L (~1.2 M) semi-crude HMF
(Fig. 3). Despite the apparent stability improvements of the ‘B’
variants, GOase M7-2A was consistently the most productive in all
reaction compositions, reaching up to 66% conversion after 24 h
with DEM as the co-solvent, remarkably approaching 100 g/L
product concentration.
A calculation of total turnover number under these conditions
with 0.05 g/L (0.71 µM) purified GOase translates to an
exceptionally high total turnover number (TTN) of 1.11 × 106
for the GOase M7-2A variant in DEM, giving an excellent
comparison to TTN ranges for other industrially applicable
biocatalysts63–67. The highest productivity though was achieved
with GOase M7-2A at 100 g/L semi-crude HMF in DEC after 6 h
(Table 6 Entry 13), reaching 12.8 g/L.h (aqueous volume only, or
7.1 g/L.h when including solvent volume) and a specific yield
1500 gDFF/genzyme. This represents a nine-fold increase in
productivity with a seven-fold increase in specific yield when
compared to the M3–5 progenitor enzyme at 1.4 g/L.h and 218
gDFF/genzyme (Supplementary Table 2 Entry 7).
In an effort to increase HMF conversion at high substrate
loadings (100 and 150 g/L semi-crude HMF in DEC), reactions
were performed with 0.1 g/L GOase M7-2A. After 6 h, 100 g/L
HMF was almost fully converted to DFF (96%), while conversion
of 150 g/L loading lagged behind (62%) (Supplementary Table 15).
In both cases extended reaction times led to little further increase
in conversion.
Preliminary reaction testing. Relatively successful preliminary
10mL scale reactions during early stage reaction engineering
provided a benchmark against which to measure reactions at
larger scale (Supplementary Table 16). GOase variants M3–5, M6-A
and M7-2A were selected to highlight the improvements in per-
formance gained through the low oxygen screening conditions
(M6-A) and recombined best mutations (M7-2A) compared to the
initial progenitor (M3–5).
Conditions for the 0.2 L reactions were evaluated to set initial
parameters to allow comparison of the variants (Supplementary
Note). After 6 h, GOase M3–5 reached 24% conversion of 50 g/L
HMF, while GOase M6-A and M7-2A had similarly improved
performance at 37 and 36% conversion, respectively (Supple-
mentary Fig. 4a and Supplementary Table 17 Entries 1–3). This
conversion was lower than expected from the analytical scale
reactions, which we surmised was at least partly due to the very
low (~50 U/mL) catalase loading compared to the analytical scale
reactions (440 or 880 U/mL) not being able to convert H2O242.
Indeed, when the catalase concentration was increased in
reactions using M7-2A, up to 59% conversion was observed after
6 h (Supplementary Fig. 4b and Supplementary Table 17 Entries
4–5) indicating that catalase activity was a limiting factor. These
reactions, however, also exhibited some foaming. Additional
complications were observed in the transition to this scale, with a
significant amount of DEC lost due to stripping in the bubbled
reactor, and the formation of emulsions, both of which would
likely influence biocatalyst performance.
By comparison to the best analytical scale reactions, the 0.2 L
reaction at high catalase loading gave a volumetric productivity of
4.8 g/L.h (aqueous volume only, or 2.6 g/L.h when including
solvent volume) and specific yield of 27.3 gDFF/gbiocatalyst as CFE,
or 516 gDFF/gbiocatalyst as pure enzyme equivalent (Supplementary
Table 17). As an additional separate validation at scale, a version
of this biphasic reaction was performed by BASF at a total volume
of 1.44 L (0.8 L aqueous, 0.64 L DEC) using 0.05 g/L GOase with
31.5 g/L HMF loading. Here, the reaction resulted in 92% isolated
yield of DFF (at a specific yield of 570 gDFF/gbiocatalyst),
demonstrating the feasibility of this reaction design.
The results presented here highlight the value of harmonizing
informed reaction and process considerations into the enzyme
engineering workflow to directly develop a biocatalyst that
balances process and enzyme requirements. Using this coordi-
nated approach to reaction and enzyme engineering, we have
developed an advanced GOase variant and corresponding
reaction conditions for effective production of the bio-based
chemical building block DFF that could be used directly in further
enzymatic (or chemo-catalytic) transformations28,68,69 to produce
other key bio-derived furans for industrial applications. The low
catalyst loading of our GOase M7-2A variant combined with the
achievement of high conversion and TTN at >1M substrate
concentrations is unique for biocatalysts active on HMF, and is
additionally distinctive in its selective oxidation to the dialdehyde
product. To the best of our knowledge, this engineered GOase
and the associated reaction conditions represent the most efficient
and selective biocatalytic production of DFF to date, and certainly
compares favourably with available chemo-catalytic synthetic
methods22,40,41.
Despite these advances, there are still several aspects that need
further work to reach and surpass the performance metrics
outlined in Table 1, in addition to a variety of considerations for
translation to industrial scale. For instance, further improvements
in enzyme stability are necessary to enable high conversion at
increased substrate loadings to elevate production titres to meet
expected production scale demands. These could potentially be
found through additional enzyme engineering to improve
aldehyde tolerance and biocatalyst lifetime, for example, but
ultimately process development at a scale that would allow in situ
product removal (ISPR)70 is likely required to bring productivity
and specific yield into a more viable range. Additionally,
replacement of HRP as GOase activator with a chemical71 or
Fig. 3 Solvent screening for improved conversion at high HMF loading.
GOase variants were evaluated for conversion of 150 g/L semi-crude HMF
to DFF in the presence of different cosolvents. Conditions: 0.05 g/L pure
enzyme, 0.0064 g/L HRP, 880 U/mL Catalase, 100mM NaPi, 150 g/L
Crude HMF in solvent (BASF), 200 µL (80% of aqueous volume) solvent
overlay, 20 °C, 24 h. No over-oxidation was observed in any of the samples.
DEC, diethyl carbonate. DEM, diethyl malonate. DES, diethyl succinate.
EGDA, ethylene glycol diacetate. Each bar represents a single experiment.
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electrochemical72 oxidant may provide a cheaper and equally
effective alternative that can be used as a ‘drop-in’ substitute
within this system. Furthermore, methods for bulk biocatalyst
production in an expression host need to be re-validated for the
GOase variant presented here, presumably based on the well-
established Pichia expression systems for GOase73. Biocatalyst
production in this way may also, at least partially, alleviate
foaming issues due to a purer biocatalyst formulation, as was
observed in the validation reaction by BASF. Finally, identifying a
continuously available carbohydrate feedstock to supply an
inexpensive and reliable method for HMF synthesis4,12–17 will
be critically important to allow uninterrupted production of DFF
for use in industry. Although these obstacles still stand in the way
of commercial production of DFF, each has significant precedent
to be achievable and the largest truly missing piece was a highly
productive (bio)catalyst for HMF oxidation. With this prototype
biocatalyst now in hand, broader production and use of these bio-
based furan polymers is closer to being in sight.
Methods
Materials. All reagents used were of the highest grade available from Sigma-Aldrich
or Fisher Scientific and used without further purification. Libraries on the GOase
M3–5 template in pET30 were synthesized by DNA2.0 to have NNK degeneration at
codons corresponding to the previously published GOase libraries A, B, C, D, E, F
and G74. Mutagenic primers were purchased from MWG Eurofins. Cell free extract
(CFE) powders were produced by Prozomix Ltd unless otherwise stated. A codon
optimized version of GOase M7-2A was used for production of M7-2A CFE for the
scale up biotransformation due to poor expression of this variant. Our standard
GOase M3–5 and GOase M6-A constructs were used for the other preparations. The
gene sequence was optimized by IDT, synthesized by LifeTechnologies and cloned
into pET30 at NheI/XhoI sites using NEBuilder according to the manufacturer’s
protocol.
Galactose oxidase expression and purification. Galactose oxidase variants were
expressed and purified as previously described75. The pET30 construct of GOase
variant was transformed into BL21 Star (DE3) cells (Invitrogen) according to
manufacturer’s protocol and grown overnight at 37 °C on LB/agar plate containing
30 µg/mL kanamycin. A single colony was picked to inoculate an overnight culture
of 5 mL LB supplemented with 30 µg/mL kanamycin and grown at 37 °C. 500 µL of
this overnight culture was used to inoculate 250 mL of 8ZY-4LAC-SUC auto-
induction media50 and grown at 26 °C for approximately 64 h. Cells were harvested
by centrifugation at 2800 × g at 4 °C for 20 min. The cell pellet was resuspended in
25 mL lysis buffer (50 mM PIPES, 25% sucrose (w/v), 5 mM MnCl2, 1% Triton
X-100 (v/v), and 1 mg/mL lysozyme and gently shaken at 4 °C for 20–30 min
before being lysed by sonication (20 s on, 20 s off, 20 cycles). The clarified lysate
(centrifuged 39000 × g for 30 min at 4 °C) was transferred to 30 kDa cut-off dialysis
tubing and dialyzed into NP buffer (50 mM NaPi, 300 mM NaCl, pH 8.0) overnight
with stirring at 4 °C. The dialyzed sample was passed through a 0.45 µm syringe
filter and applied to one or two (in series) 5 mL Strep-Tactin Superflow Plus
columns (equilibrated with NP buffer) using a peristaltic pump. The column flow
through was collected and applied to the column a second time. After loading the
crude lysate, the column was washed with 5 CV of NP buffer followed by elution
with 70 mL of NPD buffer (NP buffer with 5 mM desthiobiotin) collecting ~5 mL
fractions. Fractions containing GOase (as determined by SDS gel) were combined
and concentrated using Sartorius Vivaspin 20 (30 kDa cut-off) and then dialyzed
(30 kDa cut-off tubing) overnight at 4 °C in 50 mM NaPi pH 7.4 saturated with
CuSO4 to copper load the enzyme. Excess copper was removed by dialysis in 50
mM NaPi pH 7.4 overnight at 4 °C and protein samples were concentrated by
Vivaspin before being aliquoted and frozen in liquid N2 prior to storage at −80 °C.
Mutagenesis methods. Site-directed mutagenesis was performed following the
manufacturer’s protocol from the QuikChange II Site-Directed Mutagenesis kit
using Phusion (NEB) polymerase. Multisite-directed mutagenesis was performed
using the QuikChange Multi Site-Directed Mutagenesis kit (Agilent) according to
the manufacturer’s protocol. Primers used in the protocols are listed in Supple-
mentary Table 19.
Solid phase screen on benchtop. The solid phase GOase library screen was
performed similarly to that previously published76. The library plasmid pool was
transformed into chemically competent BL21Star(DE3) E. coli and spread onto a
nylon membrane (Roche, 132 mm) on LB/agar containing 50 µg/mL kanamycin.
After growth at 26 °C for 40 h, the library was replicated onto a new membrane and
grown at 37 °C overnight on a fresh LB/agar/kanamycin plate while the original
membrane was used for the assay. Colonies on the membrane were permeabilized
by incubation in a chloroform vapour chamber for 10 min at room temperature.
Afterward, a 10 mL solution of reaction mix containing 100 mM 1-hexanol, 0.8
mM CuSO4, 0.1 g/L HRP and 4mM 4-chloronaphthol in 100 mM NaPi, pH 7.0
with 20% DMSO was combined with 10 mL 2% agarose solution and poured over
the membrane to begin the assay. Approximately 3000 colonies per library were
screened, with colonies that turned dark purple indicating activity on 1-hexanol.
Positive clones were picked from the corresponding replicated membrane the next
day, and grown overnight in 5 mL LB supplemented with kanamycin. To confirm
hits, a small aliquot of the overnight culture was diluted in LB, re-streaked onto
nylon membranes (Roche, 82 mm) on LB/agar containing 50 µg/mL kanamycin
and grown at 26 °C for 40 h. Colonies were permeabilized and assayed as described
above combining 5 mL of both reaction mix and agarose solutions to pour over the
membrane. DNA from the top hits from the screen (i.e. those changing colour the
fastest) was collected via MiniPrep (Qiagen) from the remainder of the 5 mL
overnight culture and submitted for sequencing to identify mutations.
This assay was also performed with 25 mM 1-hexanol alcohol to screen
approximately 1000 colonies of the multisite mutagenesis library created on GOase
M4 for each substrate.
Solid phase screen in glovebox. To screen for GOase variants with improved
activity at low oxygen levels, the solid phase assay was performed as described
above for libraries C, D, and E made on the GOase M4 template with a few
modifications. Plastic ware, glassware, water bath, chloroform, water, 100 mM NaPi
pH 7.0 and 50 mM CuSO4 were placed into a glovebox and purged with nitrogen
until the oxygen sensor read ~0.2% O2 the evening before performing the assay.
Bottles and tubes of all liquids were open within the glovebox to allow dissolved
oxygen levels to equilibrate overnight. Stock solutions of HRP, 4-chloronaphthol
and HMF were made and equilibrated in the glovebox before the assay. Low-
oxygen water from the glovebox was used to dissolve agarose to make the 2%
solution, which was then returned to the glovebox, aliquoted and kept in a 55 °C
water bath until needed. After replicating the membrane, the original membrane
was transferred to the glovebox to permeabilize the colonies and begin the assay as
described above using the components equilibrated within the glovebox with 50
mM HMF as the substrate. In addition to the positive clones identified at low O2,
the speed at which colonies changed colour after removal from the glovebox was
also noted to identify further hits as necessary. As above, clones were picked from
the replicated membrane the next day, grown in LB and re-streaked onto a
membrane to validate the hits in a secondary assay at low O2. DNA from the top-
performing hits was isolated and sequenced to identify mutations.
Kinetics. Kinetic measurements were performed for purified GOase variants using
an ABTS/HRP coupled assay as previously described42. Activity was measured on a
Tecan Infinite M200 plate reader (Magellan V6.5 software) in triplicate at 30 °C.
Reactions on a 96-well plate contained 10 µL GOase dilution in 90 µL reaction mix
(containing 0.23 g/L HRP and 0.4 g/L ABTS in 100 mM sodium phosphate buffer
(NaPi) at pH 7.4. The reaction was initiated by addition of 100 µL substrate
solution in water with 20% DMSO. Initial rates were normalized by GOase con-
centration before calculating kinetic parameters using GraphPad Prism 7. Final
HMF concentrations in the 200 µL assay were 0–25 mM or 0–100 mM.
Tube-in-Tube assay for kmo determination. Reaction components were intro-
duced into the TiTR as four separate stock solutions using individual syringe
pumps. The stocks contained A) buffer, catalase, CuSO4; B) buffer, catalase, CuSO4,
HMF; C) buffer, GOase; D) buffer, HRP. It was important for HRP and GOase to
remain separate until beginning the reaction as a premixed solution lead to sig-
nificant deactivation of the GOase over the course of the experiment. Stock solu-
tions were made in 100 mM NaPi, pH 7.4. Catalase and HRP concentrations
corresponded to an activity of 20 U/mL and 1 U/mL, respectively, in the reactor.
CuSO4 in stock solutions corresponded to a concentration of 100 µM in the reactor.
GOase concentration was varied depending on activity of the variant tested to
provide and initial rate between 0.2–0.5 mmol/L/min.
Pumps were primed with the appropriate stock solution, and then set to run
continuously to reach a steady state. The mass-flow controllers were set to produce
a defined mixture of oxygen and nitrogen, and the system was set to wait a total of
three residence times for all set-points to ensure steady state had been reached.
After this, the sample was injected, and the ramp method was started. The ramp
method gradually lowers flow rate from the initial value to increase the residence
time, without changing the inlet concentration of any component. Analysis of the
reactor output provides precise time series data for the experiment. The slope of the
residence time ramp, α, was set to 0.5 for all experiments reported here, and the
ramp in flow rate was run for 15 min (real time) to provide data from a residence
time of 2 min to 10 min. Samples were collected every minute to provide
11 samples for each experiment measuring initial rate. The percentage of oxygen in
the gas and the flow rate for each syringe pump were all controlled by LabVIEW,
which automatically adjusted the set-point according to a predefined list of set-
points for the experiment.
Samples from the TiTR were analysed on the diode array UV/vis detector.
Before injection, the detector was balanced and zeroed. Once the system stabilized
and reported as ready, the injection valve was turned to inject the sample via the
flowing mobile phase. Spectral data was collected over time (20 Hz frequency) to
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collect 3-dimensional data of time-wavelength-absorbance. Absorbance was
measured from 210 to 600 nm with a slit width of 4 nm and a step width of 1 nm.
The four stock solutions were made as listed above for characterisation of the
GOase variants. The solution containing the GOase variant was pumped at a
constant ratio of 1/5 of the total flow rate through the reactor, while the flow ratio
of buffer and HMF solutions were varied according to the HMF concentration set-
point. Gas flow was kept constant at 1 NL/min, while the volume fraction of
oxygen was varied from 5–100%. The reactor was pressurized to 6 bar to provide
sufficiently high oxygen concentrations in the reaction solution.
Data handling and parameter estimation was performed using MATLAB
(MathWorks, Natick, MA, USA). Raw data from LabVIEW were converted to
concentrations of HMF and DFF using a calibration model. A linear model was
fitted to the concentration-time data to determine initial rate as slopes, and the data
was discarded if the model did not describe the data sufficiently well (R2 <0.9).
Parameters of the enzyme kinetic model (ping pong bi bi) were estimated using
non-linear least square regression and including the uncertainty of the initial rate
data. Because the UV absorbance spectra of HMF and DFF overlap, multivariate
data analysis was needed to determine the substrate and product concentrations.
To do this, a chemometric model was made and calibrated using the PLS_Toolbox
(Eigenvector Research, Manson, WA, USA) for MATLAB. Calibration curves using
for HMF and DFF using this model are shown in Supplementary Fig. 5.
Analytical Scale biotransformation and HPLC analysis. The general analytical
scale biotransformation (250 µL) contained 0.05 g/L purified GOase variant, 1.7 U/
mL (0.0064 g/L) HRP, 880 U/mL (0.08 g/L) catalase, and 250 mM HMF in 100 mM
NaPi pH 7.4. Deviations from this are described in the text and include changes in
enzyme loading, enzyme formulation, miscible or immiscible cosolvent, substrate
loading, substrate purity, buffer strength or the addition of CuSO4. After addition
of HMF to start the reaction, tubes were shaken at 250 rpm at the temperatures
described, however 20 °C was typically used. Reactions were opened every hour (up
to 8 h) to refresh oxygen in the headspace if no time point sample was needed at
the given duration.
Aliquots (10 µL) from reactions of up to 100 mM HMF with water miscible
solvents were quenched by addition to 75 µL acetonitrile and 10 µL 0.5 M H2SO4.
Samples were diluted to 500 µL with H2O, then centrifuged and transferred to a
filter vial before HPLC analysis. For reactions with higher HMF loadings, a 10 µL
aliquot was quenched in 225 µL acetonitrile and 10 µL 0.5 M H2SO4 then diluted to
1500 µL before analysis.
Reactions with water immiscible solvents were quenched by addition of 100 µL
0.5 M H2SO4 and 150 µL of the corresponding solvent. The sample was vortexed,
centrifuged, and the organic layer was removed to dry over Na2SO4. The aqueous
fraction was extracted twice with 750 µL ethyl acetate, combining all organic layers
on Na2SO4. From the aqueous fraction, a 10 µL aliquot was combined with 75 µL
acetonitrile and 415 µL H2O and then centrifuged and transferred to a filter vial for
analysis. A 250 or 500 µL aliquot of the organic layer (lower volume for higher
HMF concentration) was dried by GeneVac, and the resulting solid was dissolved
in 750 µL acetonitrile. The sample was prepared for analysis by combining 37.5 µL
of this with 37.5 µL acetonitrile, 5 µL 0.5 M H2SO4 and 420 µL H2O, centrifuged
and transferred to a filter vial for analysis.
Analysis was performed on RP-HPLC (Agilent 1200 Series, ChemStation
software or Agilent 1260 Infinity II, OpenLAB CDS software) by injection of 10 µL
onto Bio-Rad Aminex HPX-87H column. An isocratic method for 35 min with
15% acetonitrile / 85% 5mM H2SO4 at 0.5 mL/min and 60 °C was used to separate
the analytes. Absorbance at 280 nm was used for analysis after normalizing signals
to compound response factor at equal concentrations or through comparison to a
standard curve based on peak area. Crude HMF samples are analysed using a 50
min method with the same conditions. Retention times are 23.0 min for HMF, 26.9
min for DFF, 16.2 min for FFCA and 12.1 min for FDCA. Supplementary Fig. 6
shows the calibration curves for HMF, DFF, FFCA and FDCA.
Analytical scale reaction for high boiling point solvents. Analytical scale bio-
transformations with higher boiling point solvents were performed similar to as
described above. The final 250 µL reactions contained 0.05 g/L purified GOase
variant, 1.7 U/mL (0.0064 g/L) HRP, 880 U/mL (0.08 g/L) catalase in 100 mM NaPi
pH 7.4 with 100 or 150 g/L (aqueous concentration) semi-crude HMF from BASF
in the appropriate solvent (200 µL). Semi-crude HMF from BASF was provided in
diethyl carbonate. The diethyl carbonate 500 µL aliquots of this preparation was
removed by GeneVac, and the residue was dissolved in either propylene carbonate,
diethyl oxalate, diethyl malonate, diethyl succinate, ethylene glycol diethyl ether, or
ethylene glycol diacetate to give 500 µL stock solutions of the same concentration as
the original in diethyl carbonate. HMF in the respective solvent was added to start
each reaction, which were then shaken at 250 rpm at 20 °C. Reactions were opened
every hour (hours 1–6) to refresh the oxygen in the headspace.
Reactions were quenched by addition of 100 µL 0.5 M H2SO4 and 150 µL of the
corresponding solvent. The sample was vortexed, centrifuged, and the organic layer
was removed to dry over Na2SO4. The aqueous fraction was extracted twice with
750 µL ethyl acetate, combining all organic layers on Na2SO4. A sample of the dried
organic layer was diluted 20-fold in ethyl acetate prior to analysis by GC-FID
(Agilent 6850 GC, ChemStation software, Agilent HP-1, 30 m × 0.32 mm × 0.2 µm
column) using one of two methods:
Method 1: Hold 100 °C for 4 min, ramp 25 °C/min to 300 °C, hold 300 °C for 2
min
Method 2: Hold 75 °C for 7 min, ramp 25 °C/min to 300 °C, hold 300 °C for 2
min
Retention times for HMF and DFF in Method 1 are 6.1 and 4.4 min,
respectively and 10.5 and 8.2 min, respectively, in Method 2. Concentrations were
determined by comparison of peak area to a standard curve. Supplementary Fig. 7
shows the calibration curves for HMF and DFF.
From the aqueous fraction, a 10 µL aliquot was combined with 75 µL
acetonitrile and 415 µL H2O and then centrifuged and transferred to a filter vial for
analysis by HPLC as described above.
10 mL scale biotransformations. The general scaled up biotransformation (10
mL) contained 0.05 g/L purified GOase variant, 1.7 U/mL (0.0064 g/L) HRP, 880 U/
mL (0.08 g/L) catalase, and 250 mM HMF in 100 mM NaPi pH 7.4. Deviations
from this are described in the text and include changes in enzyme loading, enzyme
formulation, miscible or immiscible cosolvent, substrate loading, and substrate
purity. After addition of HMF to start the reaction, tubes were shaken at 250 rpm at
the temperatures described, however, 20 °C was typically used. Reactions were
opened every hour (up to 8 h) to refresh oxygen in the headspace if no time point
sample was needed at the given duration.
Aliquots (10 µL) from reactions with water miscible solvents were removed at
hourly time points (1–8 h) and after 24 h and quenched by addition of 150 µL
acetonitrile and 10 µL 0.5 M H2SO4 before addition of 830 µL H2O. Samples were
centrifuged and transferred to a filter vial for analysis. Samples were analysed by
HPLC as described above.
Reactions with water immiscible solvents were quenched by addition of 1.5 mL
0.5 M H2SO4. The sample was vortexed, centrifuged, and the organic layer was
removed to dry over Na2SO4. The aqueous phase was extracted twice with 20 mL
ethyl acetate, combining all organic layers over Na2SO4. From the aqueous fraction,
a 10 µL aliquot was combined with 37.5 µL acetonitrile and 202.5 µL H2O and then
centrifuged and transferred to a filter vial for analysis. A 250 µL aliquot of the
organic layer was dried by GeneVac, and the resulting solid was dissolved in 750 µL
acetonitrile. The sample was prepared for analysis by combining 37.5 µL of this
with 37.5 µL acetonitrile, 5 µL 0.5 M H2SO4 and 420 µL H2O, centrifuged and
transferred to a filter vial for analysis. Samples were analysed by HPLC as
described above.
Production of CFE for 0.2 L reactions. GOase variants M3–5, M6-A and codon
optimized M7-2A (M7-2A*) were transformed and expressed as described above.
Harvested cell pellets were resuspended in 50 mM NaPi pH 7.0 (5 mL per 1 g cell
paste) and sonicated at 1 min on (16 amps), 1.5 min off for 6–8 cycles. The sus-
pension was centrifuged at 39,000 × g for 30 min at 4 °C (Beckman Coulter Avanti
J-E), and the clarified lysates were flash frozen in liquid N2 and lyophilized. SDS gel
analysis of the CFE preparations indicates similar levels of expression for all three
variants (Supplementary Fig. 8).
Specific activities of GOase CFE. Specific activity for the three CFE preps was
performed as described above for Kinetics, with 0.05 mM CuSO4 in the reaction
mix and using 25 mM HMF (final concentration) as substrate. Initial rates were
normalized to concentration of CFE in the reactions and are presented in Sup-
plementary Table 18.
0.2 L scale reactions. All 0.2 L scale biocatalytic reactions were performed in a
250 mL bioreactor (MiniBio with my-Control from Applikon Biotechnology, Delft,
Netherlands). The reactor was equipped with a metal sparger, two Rushton tur-
bines, temperature control, a dissolved oxygen sensor and a condenser to minimize
stripping of the organic solvent layer. Samples were analysed on a Thermo Fisher
Scientific Dionex Ultimate 3000 HPLC with a Diode Array Detector. Analytes were
separated on a Bio-Rad Aminex HPX-87H column at 60 °C using an isocratic
method of 15% acetonitrile/85% 5 mM sulfuric acid as mobile phase. HMF and
DFF were analysed at both 230 and 280 nm, and the retention times were 20.4 min
and 23.4 min, respectively.
All the concentrations refer to the concentration in the aqueous phase.
Reactions were performed using 100 mM NaPi pH 7.4 as buffer and DEC as
cosolvent, 0.05 mM CuSO4, and 4 U/mL HRP, with the temperature kept
consistent at 20 °C for all experiments. Concentrations of GOase CFE, HMF and
catalase, in addition to stirring speed and aeration rate were varied as indicated to
optimize performance and compare activity of GOase variants.
Reactions were performed at a working volume of 200 mL total, split between
110 mL aqueous phase and 90 mL organic phase. Catalase was added to 109 mL
NaPi buffer in the reactor followed by 90 mL of HMF in DEC. A temperature
sensor was added and a dissolved oxygen (DO) sensor was calibrated then added to
the reactor. The DO sensor was used to monitor the activity of GOase over the
reaction. The reactor was set to the desired experimental parameters (temperature,
stirring speed, air flow rate into the reactor) and allowed to equilibrate. In a
separate tube, the specified amount of GOase variant CFE was resuspended in 1 mL
NaPi buffer, then CuSO4 and HRP were added, mixed and allowed to stand for
1–2 min to activate GOase before transferring the solution to the reactor to start
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the reaction. The amount of GOase CFE used in each experiment was adjusted to
be equivalent to 0.05 g/L purified enzyme based on comparison of specific activity
of the corresponding CFE preparation.
Samples of the reaction mixture (>1 mL) were taken at the indicated timepoints
via syringe. The sample was vortexed then 950 µL was transferred to a new tube
containing 50 µL 2M sulfuric acid and vortexed to quench the reaction. After
filtering (0.45 µm filter) the sample to remove emulsions and separating the phases,
10 µL was taken from both the organic and aqueous phases and each diluted with
427.5 µL 15% acetonitrile in water and 62.5 µL 2M sulfuric acid. A portion of this
sample was transferred to an HPLC vial for analysis on HPLC (5 µL injection) as
described above.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Source data are provided with this paper.
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